Talkspace (TALK)
NASDAQ:TALK
Top Page
Talkspace
(NASDAQ:TALK)
Select Model
Select Model
Rating:70Outperform
Price Target:
$5.50
▲(6.59% Upside)
Action:UpgradedDate:03/10/26
The score is driven by improving fundamentals (strong balance sheet and positive cash flow), constructive technical momentum, and notably upbeat 2026 guidance. These positives are tempered by an expensive valuation (high P/E), recent gross-margin compression, and the fact that net profitability is not yet consistently durable.
Positive Factors
Payor Revenue Scale
Rapid, recurring payor growth and coverage of 200M+ eligible lives indicate a durable B2B revenue base. Large payor contracts drive predictable utilization, higher retention and lower churn than D2C, supporting sustainable top-line expansion and operating leverage as integrations deepen over time.
Negative Factors
Gross Margin Compression
A sustained shift toward lower-margin payor mix has materially compressed gross margins versus earlier years. Lower unit margins reduce the cushion to cover fixed costs, limit margin expansion upside and increase dependence on scale and efficiency gains to restore historical profitability levels.
Read all positive and negative factors
Positive Factors
Negative Factors
Payor Revenue Scale
Rapid, recurring payor growth and coverage of 200M+ eligible lives indicate a durable B2B revenue base. Large payor contracts drive predictable utilization, higher retention and lower churn than D2C, supporting sustainable top-line expansion and operating leverage as integrations deepen over time.
Read all positive factors
Talkspace (TALK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$862.11M
Dividend YieldN/A
Average Volume (3M)6.50M
Price to Earnings (P/E)78.5
Beta (1Y)1.13
Revenue Growth18.37%
EPS GrowthN/A
CountryUS
Employees521
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.03
Shares Outstanding167,076,000
10 Day Avg. Volume4,841,779
30 Day Avg. Volume6,500,240
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)5.22
Price to Sales (P/S)2.67
P/FCF Ratio-290.17
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue3.60
Enterprise Value/Gross Profit8.39
Enterprise Value/Ebitda69.36
Forecast
1Y Price Target
$6.15Price Target Upside19.19% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.14
Revenue Forecast (FY)$282.80M
Talkspace Business Overview & Revenue Model
Company Description
Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples th...
How the Company Makes Money
Talkspace generates revenue primarily through subscription-based models where users pay for access to therapy services on a weekly, monthly, or quarterly basis. The company offers different subscription tiers that vary based on the type and freque...
Talkspace Earnings Call Summary
Earnings Call Date:Feb 19, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The earnings call presents strong top-line growth, accelerated Payor traction, significant adjusted EBITDA expansion and operational improvements, supported by product innovation (AI, Talkcast, psychiatry expansion) and M&A (Wisdo). There are manageable execution risks: near-term gross margin pressure from mix, reduced cash after buybacks and acquisition, deliberate de-emphasis of Consumer revenue, and uncertainty around TalkAI commercialization and Medicare penetration. Overall, the positives — recurring Payor growth, margin expansion, and confident 2026 guidance — materially outweigh the listed challenges.Positive Updates
Strong Revenue Growth (FY and Q4)
Full-year 2025 revenue of approximately $229.0M, up 22% year-over-year; Q4 2025 revenue of $63.0M, up 29.3% year-over-year.
Negative Updates
Gross Margin Compression
Q4 gross margin was 42.7%, down 169 basis points year-over-year, primarily reflecting a revenue mix shift toward the Payor channel (which drove growth but compressed gross margin in the quarter).
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Revenue Growth (FY and Q4)
Full-year 2025 revenue of approximately $229.0M, up 22% year-over-year; Q4 2025 revenue of $63.0M, up 29.3% year-over-year.
Read all positive updates
Company Guidance
Talkspace guided 2026 revenue of $275–$290 million (20–27% YoY) and adjusted EBITDA of $30–$35 million (90–122% YoY), which implies a ~23% 3‑year revenue CAGR at the midpoint; management expects a quarterly cadence with slightly less than 50% of revenue in H1, a Q4 run‑rate above $250 million (which implies ~12% growth at the midpoint), and adjusted EBITDA margins beginning the year in the high‑single digits and exiting in the mid‑teens (toward the high end of their 12–15% target). The outlook assumes Payor growth in line with 2025 (Payor revenue grew ~38% in 2025), D2E growth in the low single digits, continued intentional Consumer decline, and that a material portion (roughly 30–50%) of 2026 Payor revenue will come from members already on the platform, supported by longer Payor retention and ongoing operating‑leverage initiatives.Talkspace Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
72
Positive
Cash Flow
60
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 228.87M | 187.59M | 150.04M | 119.57M | 113.67M |
| Gross Profit | 98.35M | 85.84M | 74.38M | 60.34M | 66.77M |
| EBITDA | 11.24M | 2.10M | -22.01M | -78.06M | -60.72M |
| Net Income | 7.79M | 1.15M | -19.18M | -79.67M | -62.74M |
Balance Sheet | |||||
| Total Assets | 134.86M | 138.68M | 142.22M | 156.25M | 223.61M |
| Cash, Cash Equivalents and Short-Term Investments | 92.59M | 117.81M | 123.91M | 138.54M | 198.26M |
| Total Debt | 0.00 | 0.00 | 0.00 | 500.00K | 0.00 |
| Total Liabilities | 17.85M | 21.28M | 23.57M | 28.72M | 31.33M |
| Stockholders Equity | 117.02M | 117.39M | 118.65M | 127.54M | 192.27M |
Cash Flow | |||||
| Free Cash Flow | -2.11M | 6.26M | -16.54M | -61.43M | -66.37M |
| Operating Cash Flow | 8.53M | 11.70M | -16.39M | -61.08M | -65.71M |
| Investing Cash Flow | -28.88M | -46.73M | -141.00K | -317.00K | -663.00K |
| Financing Cash Flow | -19.00M | -12.19M | 1.90M | 1.68M | 251.38M |
Talkspace Technical Analysis
Positive
5.16
Price Trends
4.65
Positive
4.08
Positive
3.39
Positive
Market Momentum
0.14
Positive
63.87
Neutral
76.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TALK, the sentiment is Positive. The current price of 5.16 is above the 20-day moving average (MA) of 5.15, above the 50-day MA of 4.65, and above the 200-day MA of 3.39, indicating a bullish trend. The MACD of 0.14 indicates Positive momentum. The RSI at 63.87 is Neutral, neither overbought nor oversold. The STOCH value of 76.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TALK.
Talkspace Risk Analysis
Talkspace disclosed 57 risk factors in its most recent earnings report. Talkspace reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Talkspace Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $862.11M | 78.45 | 6.89% | ― | 18.37% | ― | |
59 Neutral | $2.55B | 281.23 | 0.65% | ― | 13.39% | 90.55% | |
55 Neutral | $2.43B | -1.17 | -39.42% | ― | 4.58% | -61.50% | |
54 Neutral | $309.29M | -2.77 | -24.30% | ― | -22.14% | -787.87% | |
54 Neutral | $1.77B | 11.03 | 19.58% | ― | -4.21% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $549.61M | -2.24 | -335.93% | ― | ― | -21.62% |
* Healthcare Sector Average
TALK
Talkspace
5.16
2.24
76.71%
ACHC
Acadia Healthcare
26.31
-2.79
-9.59%
CCRN
Cross Country Healthcare
9.57
-5.03
-34.45%
MD
Pediatrix Medical Group
21.38
7.28
51.63%
CMPS
COMPASS Pathways
5.72
2.87
100.70%
LFST
Lifestance Health Group
6.54
-0.37
-5.35%
Talkspace Corporate Events
Business Operations and StrategyDelistings and Listing ChangesM&A Transactions
Talkspace to be Acquired by Universal Health Services
Positive
Mar 9, 2026
On March 9, 2026, Talkspace agreed to be acquired by Universal Health Services in an all-cash merger that will see Talkspace become an indirect wholly owned subsidiary of UHS, with shareholders receiving $5.25 per share and the company’s sto...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Universal Health Services to Acquire Talkspace Virtual Platform
Positive
Mar 9, 2026
On March 9, 2026, Universal Health Services, Inc., one of the largest U.S. hospital and healthcare providers, agreed to acquire Talkspace, Inc., a Nasdaq-listed virtual behavioral health platform, for $5.25 per share in a deal valuing the target a...
Business Operations and StrategyFinancial Disclosures
Talkspace Posts Strong Q4 2025 Growth and Profitability
Positive
Feb 19, 2026
On February 19, 2026, Talkspace reported fourth-quarter and full-year 2025 results showing strong top-line growth and improved profitability driven by its payor-focused virtual mental health services. Fourth-quarter revenue rose 29% year over year...
Business Operations and StrategyFinancial Disclosures
Talkspace Highlights Growth Strategy at J.P. Morgan Conference
Positive
Jan 15, 2026
On January 15, 2026, Talkspace presented an investor deck at the 44th Annual J.P. Morgan Healthcare Conference outlining its growth trajectory, market opportunity and evolving product strategy. The company highlighted a large, underpenetrated U.S....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.